The page is the record's research on the issuer — no analyst, no rating, no view. # Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Lakewood-Amedex Biotherapeutics Inc., listed on NASDAQ under the ticker LABT. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Nevada. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 42 filings in the twelve months to 2026-11-08, across 32 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-09-29, an agm_egm filing, and is 40 days before the record date. The exchange median for NASDAQ is 6.0 days of cadence, 52 filings and 5.0 days of latency across 4359 issuers. The sector median for 2834 Pharmaceutical Preparations is 6.0 days of cadence, 63.0 filings and 4.0 days of latency across 526 issuers. The filings by type are: 16 prospectus, 11 regulatory_filing, 6 directors_dealings, 4 agm_egm, 2 results, 1 ad_hoc, 1 corporate_news and 1 director_change. ## Auditor The auditor of record is not on the record, and its location is not on the record. The latest annual report cover carries no dei:AuditorName tag, as foreign private issuers and older filings carry none. The record holds no auditor changes. ## Events and halts The record holds two listing lines, dated 2026-04-17 and 2026-04-22. No delisting and no name change are on the record. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 6 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0002079272.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/LABT (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/LABT (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/LABT · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp